Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Global Postmarket Pharmacovigilance: A Generic Drug Perspective

Journal Article · · Therapeutic Innovation & Regulatory Science
Not provided.
Research Organization:
Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN (United States)
Sponsoring Organization:
USDOE Office of Science (SC)
DOE Contract Number:
SC0014664
OSTI ID:
2425691
Journal Information:
Therapeutic Innovation & Regulatory Science, Journal Name: Therapeutic Innovation & Regulatory Science Journal Issue: 6 Vol. 57; ISSN 2168-4790
Country of Publication:
United States
Language:
English

References (5)

Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history journal January 2015
Drug and medical device product failures and the stability of the pharmaceutical supply chain journal January 2021
Ongoing Challenges in Pharmacovigilance journal November 2013
Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future journal January 2020
The Author(s) Pharmacovigilance and Risk Management Strategies 2017: Overview of the Generic Drug Program and Surveillance journal March 2019

Similar Records

An Evaluation of “Drug Ineffective” Postmarketing Reports in Drug Safety Surveillance
Journal Article · 2018 · Drugs - real world outcomes · OSTI ID:1630012

Global harmonization of immediate‐release solid oral drug product bioequivalence recommendations and the impact on generic drug development
Journal Article · 2023 · Clinical and Translational Science · OSTI ID:2471318

Environmental impacts of electricity generation: A global perspective
Journal Article · 1995 · IEEE Transactions on Energy Conversion · OSTI ID:94098